Charles A. Scanga
- Infectious Diseases top 0.5%
- Immunology top 1%
- Epidemiology top 1%
- Surgery top 5%
- Molecular Biology
- Co-authors
- JoAnne L. FlynnAlan SherAndré BáficaKathryn E. TanakaCarl G. FengAllen W. CheeverVellore P. MohanJohn Chan
- Topics
- Tuberculosis Research and Epidemiology (38 papers)Mycobacterium research and diagnosis (20 papers)Immune Response and Inflammation (13 papers)
- Partner nations
- United StatesBrazilChina
In The Last Decade
Charles A. Scanga
62 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 2.5k
- Immunology 2.1k
- Epidemiology 2.1k
- Surgery 695
- Molecular Biology 648
Countries citing papers authored by Charles A. Scanga
This map shows the geographic impact of Charles A. Scanga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles A. Scanga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles A. Scanga more than expected).
Fields of papers citing papers by Charles A. Scanga
This network shows the impact of papers produced by Charles A. Scanga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles A. Scanga. The network helps show where Charles A. Scanga may publish in the future.
Co-authorship network of co-authors of Charles A. Scanga
This figure shows the co-authorship network connecting the top 25 collaborators of Charles A. Scanga. A scholar is included among the top collaborators of Charles A. Scanga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles A. Scanga. Charles A. Scanga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 12 | |
| 6 | 10 | |
| 7 | 23 | |
| 8 | 42 | |
| 9 | 17 | |
| 10 | 38 | |
| 11 | 9 | |
| 12 | 94 | |
| 13 | 2 | |
| 14 | 476 | |
| 15 | 81 | |
| 16 | 163 | |
| 17 | 50 | |
| 18 | 389 | |
| 19 | 126 | |
| 20 | Serologic evidence of infection with lymphocytic choriomeningitis virus, the agent of callitrichid hepatitis, in primates in zoos, primate research centers, and a natural reserve | 3 |
About Charles A. Scanga
Charles A. Scanga is a scholar working on Infectious Diseases, Virology and Immunology, having authored 66 papers that have together received 4.4k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (38 papers), Mycobacterium research and diagnosis (20 papers) and Immune Response and Inflammation (13 papers). The work is most often cited by research in Infectious Diseases (2.5k citations), Immunology (2.1k citations) and Epidemiology (2.1k citations). Charles A. Scanga has collaborated with scholars based in United States, Brazil and China. Frequent co-authors include JoAnne L. Flynn, Alan Sher, André Báfica, Kathryn E. Tanaka, Carl G. Feng, Allen W. Cheever, Vellore P. Mohan, John Chan, Keming Yu and Júlio Aliberti. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.